ChemoPower is pleased to announce that we are awarded the maximum grant under the Technology Enterprise Commercialisation Scheme. This recognition from SPRING is indeed a strong validation of our company’s vision and the strong potential of our disruptive technology for the Traditional Medicines Industry.